ENG/中
美国
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerGPT
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
巨子生物
69.200
+0.850
1.24%
手動刷新
成交量:
425.34萬
成交額:
2.96億
市值:
716.91億
市盈率:
30.93
高:
71.200
開:
68.350
低:
68.000
收:
68.350
資料載入中...
總覽
公司
新聞
公告
南向資金12月11日淨賣出鉅子生物3.86萬股 連續3日減持
市场透视
·
2024-12-12
鉅子生物12月11日主力資金流出125萬元 連續3日減倉
市场透视
·
2024-12-11
鉅子生物盤中異動 快速拉昇5.08%報53.750港元
市场透视
·
2024-12-10
醫藥股再獲資金關注 鉅子生物大漲超8%
市场资讯
·
2024-12-06
異動解讀 | 鉅子生物股價盤中大漲6.86% 主力產品獲優先審批 增強長期發展信心
异动解读
·
2024-12-06
【港股通】鉅子生物(02367)升逾7% “注射用重組膠原蛋白填充劑”獲優先審批
金吾财讯
·
2024-12-06
港股異動 | 鉅子生物(02367)漲超8% 旗下“注射用重組膠原蛋白填充劑”獲優先審批
智通财经
·
2024-12-06
鉅子生物(02367)上漲7.5%,報50.9元/股
金融界
·
2024-12-06
鉅子生物盤中異動 股價大漲6.65%報50.500港元
市场透视
·
2024-12-06
【券商聚焦】美銀:中國本土化妝品品牌崛起與洗牌 國際品牌價格穩定性是關鍵
金吾财讯
·
2024-12-04
【券商聚焦】招銀國際:多款重磅國產創新藥納入醫保 基金收支有望改善
金吾财讯
·
2024-12-03
鉅子生物12月03日主力資金流入1848萬元 連續5日加倉
市场透视
·
2024-12-03
招銀國際:醫保持續支持創新 基金收支有望改善
智通财经
·
2024-12-03
鉅子生物12月2日獲南向資金加倉95.22萬股
市场透视
·
2024-12-03
鉅子生物12月02日獲主力加倉2875萬元 環比增加3204.60%
市场透视
·
2024-12-02
鉅子生物11月29日主力資金流入87萬元 連續3日加倉
市场透视
·
2024-11-29
山西女教師“誤闖”醫美圈,身家95億
财经天下WEEKLY
·
2024-11-29
鉅子生物:雙 11 旗下品牌高增長 4.69%
和讯网
·
2024-11-27
鉅子生物現漲近5% 可復美與可麗金雙11表現或支撐公司達成全年盈利目標
新浪港股
·
2024-11-27
異動解讀 | 鉅子生物(02367)盤中股價大漲5% 可復美與可麗金品牌雙11表現強勁或支撐達成全年盈利目標
异动解读
·
2024-11-27
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02367/news?page=9"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02367","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02367\",,,,,undefined,":{"symbol":"02367","market":"HK","secType":"STK","nameCN":"巨子生物","latestPrice":69.2,"timestamp":1744358899032,"preClose":68.35,"halted":0,"volume":4253415,"delay":0,"floatShares":1036000000,"shares":1036000000,"eps":2.2372011499127473,"marketStatus":"休市中","change":0.85,"latestTime":"04-11 16:08:19","open":68.35,"high":71.2,"low":68,"amount":296282739,"amplitude":0.046818,"askPrice":69.3,"askSize":15400,"bidPrice":69.2,"bidSize":80800,"shortable":3,"etf":0,"ttmEps":2.1942220705316635,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1744594200000},"marketStatusCode":7,"adr":0,"listingDate":1667491200000,"exchange":"SEHK","adjPreClose":68.35,"dividendRate":0.014017,"openAndCloseTimeList":[[1744335000000,1744344000000],[1744347600000,1744358400000]],"volumeRatio":0.78054938857328,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02367\",,,,,undefined,":{"symbol":"02367","floatShares":1036000000,"roa":"21.88%","roe":"35.88%","lyrEps":2.237201,"volumeRatio":0.78054938857328,"shares":1036000000,"dividePrice":0.97,"high":71.2,"amplitude":0.046818,"preClose":68.35,"low":68,"week52Low":35,"pbRate":"9.47","psRate":"12.15","week52High":75.2,"institutionHeld":0,"latestPrice":69.2,"committee":0.679834,"eps":2.2372011499127473,"divideRate":0.014017,"volume":4253415,"delay":0,"ttmEps":2.1942220705316635,"open":68.35,"prevYearClose":49.9,"prevWeekClose":71.4,"prevMonthClose":70.45,"prevQuarterClose":70.45,"fiveDayClose":71.4,"twentyDayClose":69.65,"sixtyDayClose":48.75},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02367\",pageSize:20,pageCount:9,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2490846783","title":"南向資金12月11日淨賣出鉅子生物3.86萬股 連續3日減持","url":"https://stock-news.laohu8.com/highlight/detail?id=2490846783","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490846783?lang=zh_tw&edition=fundamental","pubTime":"2024-12-12 09:30","pubTimestamp":1733967023,"startTime":"0","endTime":"0","summary":"12月11日,南向资金减持巨子生物3.86万股连续3日减持。截止当日收盘,港股通共持有巨子生物17065.54万股,占流通股16.58%。巨子生物近5个交易日上涨2.86%,港股通累计减持206.58万股;近20个交易日下跌1.76%,港股通累计减持331.08万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212093230ab710123&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212093230ab710123&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1207","02367"],"gpt_icon":0},{"id":"2490688061","title":"鉅子生物12月11日主力資金流出125萬元 連續3日減倉","url":"https://stock-news.laohu8.com/highlight/detail?id=2490688061","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490688061?lang=zh_tw&edition=fundamental","pubTime":"2024-12-11 16:16","pubTimestamp":1733904995,"startTime":"0","endTime":"0","summary":"12月11日, 巨子生物股价跌1.08%,报收50.30元,成交金额1.19亿元,换手率0.23%,振幅3.15%,量比0.53。巨子生物今日主力资金净流出125万元,连续3日净流出,上一交易日主力净流出147万元,今日环比减少14.97%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为37.50%,平均跌幅为2.41%。该股近5个交易日上涨2.56%,主力资金累计净流入2874万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入1.06亿元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211161703ab6efad5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211161703ab6efad5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","LU2488822045.USD","02367"],"gpt_icon":0},{"id":"2490039017","title":"鉅子生物盤中異動 快速拉昇5.08%報53.750港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490039017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490039017?lang=zh_tw&edition=fundamental","pubTime":"2024-12-10 09:38","pubTimestamp":1733794713,"startTime":"0","endTime":"0","summary":"2024年12月10日早盘09时38分,巨子生物股票出现异动,股价急速拉升5.08%。截至发稿,该股报53.750港元/股,成交量65.98万股,换手率0.06%,振幅3.91%。资金方面,该股资金流入1680.09万港元,流出902.651万港元。巨子生物股票所在的生物技术行业中,整体涨幅为0.99%。其相关个股中,思路迪医药股份、百奥赛图-B、贝康医疗-B涨幅较大,振幅较大的相关个股有晶泰控股-P、来凯医药-B、药明巨诺-B,振幅分别为11.30%、8.29%、7.91%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210093833a1e1f318&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210093833a1e1f318&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","LU2488822045.USD","02367"],"gpt_icon":0},{"id":"2489074423","title":"醫藥股再獲資金關注 鉅子生物大漲超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489074423","media":"市场资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489074423?lang=zh_tw&edition=fundamental","pubTime":"2024-12-06 10:24","pubTimestamp":1733451840,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 财联社12月6日讯 今日港股医药股多数上涨。截至发稿,云康集团、永泰生物-B、巨子生物、宜明昂科-B()分别上涨16.67%、11.54%、8.13%、6.27%。 从上图来看,巨子生物表现居前,该公司一度涨近9%。 宜明昂科近日发布公告,宣布公司已获中国国家药监局批准进行IMM0306用于治疗狼疮性肾炎的II期临床试验。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2024-12-06/doc-incynvuq5706618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","159938","BK1207","LU2488822045.USD","BK1515","02367","09939","BK1161"],"gpt_icon":0},{"id":"1167613969","title":"異動解讀 | 鉅子生物股價盤中大漲6.86% 主力產品獲優先審批 增強長期發展信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1167613969","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167613969?lang=zh_tw&edition=fundamental","pubTime":"2024-12-06 10:21","pubTimestamp":1733451690,"startTime":"0","endTime":"0","summary":"生物科技公司巨子生物(02367)今日盘中大涨6.86%,引起市场广泛关注。\n\n利好消息是,巨子生物旗下主力产品\"注射用重组胶原蛋白填充剂\"获得国家药监局批准优先审评。该产品属于国家重点研发计划范畴,有望加快上市进程。\n\n作为巨子生物重要收入来源,这款产品的利好消息无疑增强了市场对公司长期发展前景的信心。投资者预期公司未来将从产品上市销售中获益,推升股价大涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02367"],"gpt_icon":0},{"id":"2489142531","title":"【港股通】鉅子生物(02367)升逾7% “注射用重組膠原蛋白填充劑”獲優先審批","url":"https://stock-news.laohu8.com/highlight/detail?id=2489142531","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489142531?lang=zh_tw&edition=fundamental","pubTime":"2024-12-06 09:54","pubTimestamp":1733450067,"startTime":"0","endTime":"0","summary":"金吾财讯 | 巨子生物 早盘股价震荡扬升,截至发稿,涨7.07%,报50.7港元,成交额7460.71万港元。据《结果公示》,巨子生物的“注射用重组胶原蛋白填充剂”属于“列入国家重点研发计划的医疗器械”,符合优先审批情形的项目,拟定予以优先审批。该行表示,公司作为重组胶原蛋白龙头,凭借多元化产品矩阵和渠道优势,业绩有望持续高增。维持“买入”评级。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/YjNiOTNjODIxNjM4MTUzMTI5MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjNiOTNjODIxNjM4MTUzMTI5MQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1949110","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1207","YANG","HSTECH","07226","02367","HSCEI","LU2488822045.USD"],"gpt_icon":0},{"id":"2489447224","title":"港股異動 | 鉅子生物(02367)漲超8% 旗下“注射用重組膠原蛋白填充劑”獲優先審批","url":"https://stock-news.laohu8.com/highlight/detail?id=2489447224","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489447224?lang=zh_tw&edition=fundamental","pubTime":"2024-12-06 09:37","pubTimestamp":1733449037,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,巨子生物(02367)涨超8%,截至发稿,涨8.87%,报51.55港元,成交额4957.53万港元。消息面上,12月5日,国家药品监督管理局医疗器械技术审评中心(CMDE)发布《医疗器械优先审批申请审核结果公示(2024年第17号)》(简称“《结果公示》”)。据《结果公示》,巨子生物的“注射用重组胶原蛋白填充剂(受理号:CQZ2402149)”属于“列入国家重点研发计划的医疗器械”,符合优先审批情形的项目,拟定予以优先审批。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1221201.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02367","BK1207","LU2488822045.USD"],"gpt_icon":0},{"id":"2489447930","title":"鉅子生物(02367)上漲7.5%,報50.9元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2489447930","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489447930?lang=zh_tw&edition=fundamental","pubTime":"2024-12-06 09:30","pubTimestamp":1733448610,"startTime":"0","endTime":"0","summary":"12月6日,巨子生物(02367)盘中上涨7.5%,截至09:30,报50.9元/股,成交335.37万元。巨子生物主营业务为研发和生产功效性护肤品、医疗器械和功能性食品,核心技术是采用自有的合成生物学技术开发重组胶原蛋白和稀有人参皂苷等生物活性成分。公司拥有93项专利和专利申请,其重组胶原蛋白技术在中国是首个获得专利的,并曾两次获得重要的技术奖励。截至2024年中报,巨子生物营业总收入25.4亿元、净利润9.83亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/06093046085870.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1207","02367","LU2488822045.USD"],"gpt_icon":0},{"id":"2489644016","title":"鉅子生物盤中異動 股價大漲6.65%報50.500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489644016","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489644016?lang=zh_tw&edition=fundamental","pubTime":"2024-12-06 09:30","pubTimestamp":1733448606,"startTime":"0","endTime":"0","summary":"2024年12月06日早盘09时30分,巨子生物股票出现异动,股价急速上涨6.65%。截至发稿,该股报50.500港元/股,成交量4.92万股,换手率0.00%,振幅1.37%。资金方面,该股资金流入27.385万港元,流出37.104万港元。巨子生物股票所在的生物技术行业中,整体涨幅为0.37%。其相关个股中,巨子生物、歌礼制药-B、乐普生物-B涨幅较大,振幅较大的相关个股有再鼎医药、乐普生物-B、巨子生物,振幅分别为2.05%、1.50%、1.06%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206093006a1d7ce9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206093006a1d7ce9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367","LU2488822045.USD","BK1207"],"gpt_icon":0},{"id":"2488322156","title":"【券商聚焦】美銀:中國本土化妝品品牌崛起與洗牌 國際品牌價格穩定性是關鍵","url":"https://stock-news.laohu8.com/highlight/detail?id=2488322156","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488322156?lang=zh_tw&edition=fundamental","pubTime":"2024-12-04 16:07","pubTimestamp":1733299649,"startTime":"0","endTime":"0","summary":"专家认为,本土品牌在未来几年将继续从国际品牌中夺取市场份额。对于国际品牌而言,报告指出其在中国市场份额的下降原因包括:1) 在免税渠道上的渠道库存清理导致价格不稳定和品牌形象稀释;2) 国际品牌从线下开始,较慢地转向线上。分销商不认为国际品牌通过小规模和样品尺寸的SKU进入低线城市是正确的选择,因为这可能会进一步破坏价格稳定。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/YzM1MzBiNWM5MmUxNDYxMGFiODk0MWI5MWJmNTU3YjMxMTA4MTkwNzI1ODY3.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YzM1MzBiNWM5MmUxNDYxMGFiODk0MWI5MWJmNTU3YjMxMTA4MTkwNzI1ODY3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1948971","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367","BK1207","02145","LU2488822045.USD"],"gpt_icon":0},{"id":"2488962929","title":"【券商聚焦】招銀國際:多款重磅國產創新藥納入醫保 基金收支有望改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2488962929","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488962929?lang=zh_tw&edition=fundamental","pubTime":"2024-12-03 17:22","pubTimestamp":1733217761,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际发研指,MSCI中国医疗指数年初至今累计下跌17.6%,跑输MSCI中国指数30.1%。新版医保目录已公布,多款重磅国产创新药纳入,该行预期续约品种价格降幅较温和,体现医保基金持续大力支持创新药。今年9、10月份,基本医疗保险的收支结余显著改善。随着政策焦点转向刺激经济,该行认为医保基金收支状况有望大幅改善。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/YzM1MzBiNWM5MmUxNDYxMGFiODk0MWI5MWJmNTU3YjMxMTA4MTkwNzI1ODY3.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YzM1MzBiNWM5MmUxNDYxMGFiODk0MWI5MWJmNTU3YjMxMTA4MTkwNzI1ODY3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1948888","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367","159992","01530","LU0588546209.SGD","LU1969619763.USD","BK1583","BK1574","06160","BK1588","BK1141","LU0307460666.USD","06978","LU2125910500.SGD","LU0052750758.USD","02359","01801","BK1207","LU0196878994.USD","BK1161","BK1589","06990","BK1500","BK1576","LU2045819591.USD","BK1593","LU0320764599.SGD","LU0708995583.HKD","LU2242644610.SGD","LU2488822045.USD","LU1046422090.SGD","LU2328871848.SGD"],"gpt_icon":0},{"id":"2488405998","title":"鉅子生物12月03日主力資金流入1848萬元 連續5日加倉","url":"https://stock-news.laohu8.com/highlight/detail?id=2488405998","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488405998?lang=zh_tw&edition=fundamental","pubTime":"2024-12-03 16:15","pubTimestamp":1733213709,"startTime":"0","endTime":"0","summary":"12月03日, 巨子生物股价涨1.86%,报收49.20元,成交金额1.70亿元,换手率0.34%,振幅4.45%,量比0.93。巨子生物今日主力资金净流入1848万元,连续5日净流入,上一交易日主力净流入2875万元,今日环比减少35.72%。近一年数据显示,该股主力连续5日净流入后,次日上涨概率为57.14%,平均涨幅为3.54%。该股近5个交易日上涨0.51%,主力资金累计净流入7547万元,其中2个交易日为股价下跌时净流入;近20日主力资金累计净流入9729万元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203161521abf2275d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203161521abf2275d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","02367"],"gpt_icon":0},{"id":"2488357962","title":"招銀國際:醫保持續支持創新 基金收支有望改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2488357962","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488357962?lang=zh_tw&edition=fundamental","pubTime":"2024-12-03 15:22","pubTimestamp":1733210537,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,招银国际发布研报称,随着政策焦点转向刺激经济,医保基金收支状况有望大幅改善。2024年医保目录调整结果已公布,新增91种药品,医保支持创新。此外,医保局医保数据赋能商业保险公司推进的探索,未来高价创新药械或将通过医保与商业保险的协同获得更好的报销覆盖。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1219572.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1997245177.USD","01530","LU1997245094.SGD","BK1574","BK1589","LU0456842615.SGD","LU2488822045.USD","LU0196878994.USD","BK1207","LU1969619763.USD","688235","BK1161","02367","BK0216","BK1593","LU2328871848.SGD","06978","06990","603259","BK0251","01801","BK1583","BK0239","688271"],"gpt_icon":0},{"id":"2488939446","title":"鉅子生物12月2日獲南向資金加倉95.22萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2488939446","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488939446?lang=zh_tw&edition=fundamental","pubTime":"2024-12-03 09:30","pubTimestamp":1733189414,"startTime":"0","endTime":"0","summary":"12月2日, 南向资金增持巨子生物95.22万股。截止当日收盘,港股通共持有巨子生物17320.68万股,占流通股16.83%。巨子生物近5个交易日下跌3.88%,港股通累计增持122.62万股;近20个交易日下跌10.72%,港股通累计减持279.65万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203093204abf14523&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203093204abf14523&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367","BK1207"],"gpt_icon":0},{"id":"2488962314","title":"鉅子生物12月02日獲主力加倉2875萬元 環比增加3204.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488962314","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488962314?lang=zh_tw&edition=fundamental","pubTime":"2024-12-02 16:16","pubTimestamp":1733127369,"startTime":"0","endTime":"0","summary":"12月02日, 巨子生物股价跌3.40%,报收48.30元,成交金额2.79亿元,换手率0.55%,振幅5.90%,量比1.69。巨子生物今日主力资金净流入2875万元,连续4日净流入,上一交易日主力净流入87万元,今日环比增加3204.60%。近一年数据显示,该股主力连续4日净流入后,次日上涨概率为90.00%,平均涨幅为2.08%。该股近5个交易日下跌5.07%,主力资金累计净流入5060万元;近20日主力资金累计净流入8675万元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202161647abef2358&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202161647abef2358&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","02367"],"gpt_icon":0},{"id":"2487580669","title":"鉅子生物11月29日主力資金流入87萬元 連續3日加倉","url":"https://stock-news.laohu8.com/highlight/detail?id=2487580669","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487580669?lang=zh_tw&edition=fundamental","pubTime":"2024-11-29 16:16","pubTimestamp":1732868172,"startTime":"0","endTime":"0","summary":"11月29日, 巨子生物股价涨2.15%,报收50.00元,成交金额1.33亿元,换手率0.26%,振幅3.58%,量比0.81。巨子生物今日主力资金净流入87万元,连续3日净流入,上一交易日主力净流入1498万元,今日环比减少94.19%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为42.86%,平均涨幅为1.87%。该股近5个交易日上涨1.11%,主力资金累计净流入2094万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入6570万元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129161644a25ea1f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129161644a25ea1f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367","BK1207"],"gpt_icon":0},{"id":"2487303144","title":"山西女教師“誤闖”醫美圈,身家95億","url":"https://stock-news.laohu8.com/highlight/detail?id=2487303144","media":"财经天下WEEKLY","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487303144?lang=zh_tw&edition=fundamental","pubTime":"2024-11-29 11:34","pubTimestamp":1732851281,"startTime":"0","endTime":"0","summary":"三晋商脉,自古有名。而眼下山西商业中“最会赚钱”的,是一位女性医美大佬。这位医美大佬掌舵的锦波生物,在今年前三个季度,净利润达5.2亿元,增长了170%。毛利率在第三季度更是达到了93.6%,甚至超过了贵州茅台。撑起锦波生物这支“医美茅”的,是时下最流行的美容产品——重组胶原蛋白水光针。用这种针美容,一个疗程动...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/ONlfiX_EHt5ll9wDovu_JXDieQ1vGGe9SP7SxABnYWCIkAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/ONlfiX_EHt5ll9wDovu_JXDieQ1vGGe9SP7SxABnYWCIkAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241129A03LNK00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241129A03LNK00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK1207","09997","BK1222","BK1583","BK1574","02367","BK1100","09996"],"gpt_icon":0},{"id":"2486953028","title":"鉅子生物:雙 11 旗下品牌高增長 4.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486953028","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486953028?lang=zh_tw&edition=fundamental","pubTime":"2024-11-27 11:54","pubTimestamp":1732679685,"startTime":"0","endTime":"0","summary":"【巨子生物早盘上涨 4.69%,现报 51.30 港元,成交额 1.32 亿港元】浦银国际发布研报称,2024 年“双 11”期间,巨子生物旗下两大品牌可复美及可丽金再次实现高增长。 据公司“双 11”战报,可复美与可丽金线上全渠道 GMV 分别同比增长 80%+和 150%+。可复美高速增长,且较今年“618”增速提升。 该行持续看好重组胶原蛋白行业及公司化妆品产品高速增长,认为公司两大品牌“双 11”大促期间的高速增长,支撑公司达成全年盈利目标(收入和经调净利润分别同比提升略高于 40%和 35%左右)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127122841abe244b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127122841abe244b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","02367"],"gpt_icon":0},{"id":"2486867896","title":"鉅子生物現漲近5% 可復美與可麗金雙11表現或支撐公司達成全年盈利目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2486867896","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486867896?lang=zh_tw&edition=fundamental","pubTime":"2024-11-27 11:10","pubTimestamp":1732677051,"startTime":"0","endTime":"0","summary":"巨子生物早盘上涨4.69%,现报51.30港元,成交额1.32亿港元。 浦银国际发布研报称,2024年“双11”期间巨子生物旗下两大品牌可复美及可丽金再次录得高增长。根据公司“双11”战报,可复美与可丽金线上全渠道GMV分别同比增长80%+和150%+。可复美的高速增长喜人,也较今年“618”的增速有所提升。持续看好重组胶原蛋白行业以及公司化妆品产品的高速增长。该行认为,公司两大品牌在“双11”大促期间高速的增长支撑公司达成全年盈利目标。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-11-27/doc-incxnmtn6941392.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-11-27/doc-incxnmtn6941392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["BK1207","02367"],"gpt_icon":0},{"id":"1135869263","title":"異動解讀 | 鉅子生物(02367)盤中股價大漲5% 可復美與可麗金品牌雙11表現強勁或支撐達成全年盈利目標","url":"https://stock-news.laohu8.com/highlight/detail?id=1135869263","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135869263?lang=zh_tw&edition=fundamental","pubTime":"2024-11-27 10:48","pubTimestamp":1732675715,"startTime":"0","endTime":"0","summary":"今日巨子生物股价盘中大涨5%,引发了市场广泛关注。根据消息,这次股价上涨或与巨子生物旗下两大品牌可复美及可丽金在双11期间取得亮眼销售业绩有关。如此强劲的双11表现,有望支撑巨子生物今年能够顺利达成收入和经调净利润目标,分别同比提升40%和35%左右。行业专家认为,巨子生物此次在双11期间取得较好业绩,很大程度源于其对头部主播及直播间营销的持续投入。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02367"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02367\",params:#limit:5,,,undefined,":[{"date":"2025-06-17","symbol":"02367","amount":0.5921,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-06-18","defaultRemindTime":1750123800000,"name":"巨子生物","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-29","payableDate":"2025-06-18","currency":"CNY","dateTimestamp":1750089600000,"payDate":"2025-08-29"},{"date":"2025-03-26","symbol":"02367","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742952600000,"name":null,"time":"盤後","dateTimestamp":1742918400000,"actualEps":null},{"date":"2024-08-19","symbol":"02367","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"盤後","dateTimestamp":1723996800000,"actualEps":null},{"date":"2024-06-17","symbol":"02367","amount":0.97,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2024-06-18","defaultRemindTime":1718587800000,"name":"巨子生物","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-05","payableDate":"2024-06-18","currency":"HKD","dateTimestamp":1718553600000,"payDate":"2024-07-05"},{"date":"2024-03-25","symbol":"02367","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02367\",market:\"HK\",,,undefined,":[{"executeDate":"2024-06-17","recordDate":"2024-06-18","paymentDate":"2024-07-05","value":0.97,"currency":"HKD"},{"executeDate":"2025-06-17","recordDate":"2025-06-18","paymentDate":"2025-08-29","value":0.5921,"currency":"CNY"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02367\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":20,"updateTime":1744128000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02367\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02367","date":"2025-04-11","current":32.158951,"percent":0.718121,"low":18.546195,"twenty":25.847354,"median":29.194481,"eighty":33.675182,"high":60.214956,"avg":30.412552,"sd":6.586328,"marketCap":70369756800},"quantilePoints":[{"date":"2022-11-04","current":28.694216,"twenty":26.512834,"median":26.542085,"eighty":27.833364,"marketCap":25968654960},{"date":"2022-11-11","current":35.577583,"twenty":27.402937,"median":34.819032,"eighty":37.211633,"marketCap":32485133920},{"date":"2022-11-18","current":30.409033,"twenty":29.071802,"median":32.325114,"eighty":36.373143,"marketCap":27670720360},{"date":"2022-11-25","current":29.089974,"twenty":29.309257,"median":30.328688,"eighty":34.970742,"marketCap":26260437600},{"date":"2022-12-02","current":29.440115,"twenty":28.58665,"median":29.786096,"eighty":33.378719,"marketCap":27035200000},{"date":"2022-12-09","current":33.170723,"twenty":28.69893,"median":30.328688,"eighty":33.541593,"marketCap":30744000000},{"date":"2022-12-16","current":33.617702,"twenty":28.859591,"median":31.890871,"eighty":33.525219,"marketCap":31085600000},{"date":"2022-12-23","current":32.235512,"twenty":29.23003,"median":32.061881,"eighty":33.375102,"marketCap":29816800000},{"date":"2022-12-30","current":35.028223,"twenty":29.440115,"median":32.235512,"eighty":33.644993,"marketCap":32793600000},{"date":"2023-01-06","current":34.259259,"twenty":29.598569,"median":32.356077,"eighty":33.906187,"marketCap":32403200000},{"date":"2023-01-13","current":37.514633,"twenty":29.683286,"median":32.593587,"eighty":35.138095,"marketCap":36160800000},{"date":"2023-01-20","current":39.320225,"twenty":29.767789,"median":33.170723,"eighty":36.075015,"marketCap":37576000000},{"date":"2023-01-27","current":41.405428,"twenty":29.847916,"median":33.242723,"eighty":36.22764,"marketCap":39576800000},{"date":"2023-02-03","current":46.017337,"twenty":30.125824,"median":33.502098,"eighty":37.981351,"marketCap":44212800000},{"date":"2023-02-10","current":48.646066,"twenty":30.280481,"median":33.687805,"eighty":39.317619,"marketCap":46457600000},{"date":"2023-02-17","current":47.305048,"twenty":30.475064,"median":33.964048,"eighty":41.148897,"marketCap":44749600000},{"date":"2023-02-24","current":46.898265,"twenty":30.969524,"median":34.88282,"eighty":44.591745,"marketCap":43822400000},{"date":"2023-03-03","current":48.206405,"twenty":31.89643,"median":35.69024,"eighty":46.759698,"marketCap":45335200000},{"date":"2023-03-17","current":60.214956,"twenty":31.932315,"median":36.041848,"eighty":47.552658,"marketCap":56754400000},{"date":"2023-03-24","current":51.699724,"twenty":32.016899,"median":36.568073,"eighty":48.347792,"marketCap":49288000000},{"date":"2023-03-31","current":40.925047,"twenty":32.156582,"median":37.514633,"eighty":48.347792,"marketCap":46848000000},{"date":"2023-04-06","current":40.652856,"twenty":32.21578,"median":38.432644,"eighty":48.279626,"marketCap":46506400000},{"date":"2023-04-14","current":37.246115,"twenty":32.289273,"median":38.307612,"eighty":48.226605,"marketCap":42651200000},{"date":"2023-04-21","current":33.385259,"twenty":32.343692,"median":38.098031,"eighty":47.893759,"marketCap":38210400000},{"date":"2023-04-28","current":30.285025,"twenty":32.289273,"median":37.591448,"eighty":47.642868,"marketCap":34404000000},{"date":"2023-05-05","current":26.161165,"twenty":31.945964,"median":37.33158,"eighty":47.490756,"marketCap":29768000000},{"date":"2023-05-12","current":30.574645,"twenty":30.692284,"median":36.23263,"eighty":47.274687,"marketCap":34550400000},{"date":"2023-05-19","current":31.711515,"twenty":30.746535,"median":35.923479,"eighty":47.115193,"marketCap":35331200000},{"date":"2023-05-25","current":31.182824,"twenty":30.822604,"median":35.69024,"eighty":46.935066,"marketCap":34599200000},{"date":"2023-06-02","current":32.039153,"twenty":30.742861,"median":35.028223,"eighty":46.759698,"marketCap":35428800000},{"date":"2023-06-09","current":32.262222,"twenty":30.684805,"median":34.15987,"eighty":46.167812,"marketCap":35624000000},{"date":"2023-06-16","current":32.772734,"twenty":30.742861,"median":33.693297,"eighty":45.892894,"marketCap":36014400000},{"date":"2023-06-23","current":31.032471,"twenty":30.757557,"median":33.682729,"eighty":45.395124,"marketCap":33916000000},{"date":"2023-06-30","current":31.360803,"twenty":30.757557,"median":33.502098,"eighty":44.617559,"marketCap":33964800000},{"date":"2023-07-07","current":31.376956,"twenty":30.759705,"median":33.358016,"eighty":44.488487,"marketCap":33916000000},{"date":"2023-07-14","current":31.254408,"twenty":30.81937,"median":33.206723,"eighty":42.385946,"marketCap":34257600000},{"date":"2023-07-21","current":29.61115,"twenty":30.759705,"median":32.931722,"eighty":41.535665,"marketCap":32305600000},{"date":"2023-07-28","current":31.165322,"twenty":30.717545,"median":32.723027,"eighty":41.405428,"marketCap":33964800000},{"date":"2023-08-04","current":32.76763,"twenty":30.739187,"median":32.639512,"eighty":41.393979,"marketCap":35770400000},{"date":"2023-08-11","current":32.773868,"twenty":30.757557,"median":32.603384,"eighty":41.176747,"marketCap":35575200000},{"date":"2023-08-18","current":30.610294,"twenty":30.757557,"median":32.513854,"eighty":41.037499,"marketCap":32988800000},{"date":"2023-08-25","current":31.726668,"twenty":30.759705,"median":32.346784,"eighty":40.925047,"marketCap":34208800000},{"date":"2023-09-01","current":27.573424,"twenty":30.671209,"median":32.32831,"eighty":40.652856,"marketCap":36697600000},{"date":"2023-09-08","current":26.75169,"twenty":30.572064,"median":32.277824,"eighty":40.648282,"marketCap":35184800000},{"date":"2023-09-15","current":25.993592,"twenty":30.285025,"median":32.235512,"eighty":40.62978,"marketCap":34452800000},{"date":"2023-09-22","current":25.737943,"twenty":29.809068,"median":32.045764,"eighty":40.128892,"marketCap":33964800000},{"date":"2023-09-29","current":25.066298,"twenty":29.656075,"median":31.997803,"eighty":39.81665,"marketCap":33135200000},{"date":"2023-10-06","current":25.484582,"twenty":29.406098,"median":31.918666,"eighty":39.533705,"marketCap":33672000000},{"date":"2023-10-13","current":24.08012,"twenty":28.952772,"median":31.841433,"eighty":39.348774,"marketCap":31768800000},{"date":"2023-10-20","current":22.598372,"twenty":28.090884,"median":31.767659,"eighty":39.309801,"marketCap":29768000000},{"date":"2023-10-27","current":22.348635,"twenty":27.619397,"median":31.711663,"eighty":39.282609,"marketCap":29426400000},{"date":"2023-11-03","current":25.394448,"twenty":27.541831,"median":31.642548,"eighty":39.168886,"marketCap":33525600000},{"date":"2023-11-10","current":25.843419,"twenty":27.016595,"median":31.492944,"eighty":38.901953,"marketCap":34111200000},{"date":"2023-11-17","current":25.355932,"twenty":26.744612,"median":31.467436,"eighty":38.544946,"marketCap":33769600000},{"date":"2023-11-24","current":25.803053,"twenty":26.578324,"median":31.402883,"eighty":38.289787,"marketCap":34648000000},{"date":"2023-12-01","current":25.805078,"twenty":26.361375,"median":31.373452,"eighty":38.186355,"marketCap":34794400000},{"date":"2023-12-08","current":23.911147,"twenty":26.187226,"median":31.314709,"eighty":38.124793,"marketCap":32110400000},{"date":"2023-12-15","current":23.015122,"twenty":25.978956,"median":31.279712,"eighty":37.928033,"marketCap":31085600000},{"date":"2023-12-22","current":23.970526,"twenty":25.934891,"median":31.256547,"eighty":37.726838,"marketCap":32354400000},{"date":"2023-12-29","current":25.605578,"twenty":25.922833,"median":31.253927,"eighty":37.637537,"marketCap":34745600000},{"date":"2024-01-05","current":24.881987,"twenty":25.805078,"median":31.237017,"eighty":37.514633,"marketCap":33525600000},{"date":"2024-01-12","current":25.701327,"twenty":25.757517,"median":31.165322,"eighty":37.417045,"marketCap":34648000000},{"date":"2024-01-19","current":24.032983,"twenty":25.700075,"median":31.138965,"eighty":37.246115,"marketCap":32354400000},{"date":"2024-01-26","current":24.563567,"twenty":25.531167,"median":31.049171,"eighty":36.903516,"marketCap":32940000000},{"date":"2024-02-02","current":22.773078,"twenty":25.419215,"median":30.993085,"eighty":36.23263,"marketCap":30500000000},{"date":"2024-02-09","current":24.329361,"twenty":25.355932,"median":30.81937,"eighty":36.207681,"marketCap":32744800000},{"date":"2024-02-16","current":25.846624,"twenty":25.369207,"median":30.758631,"eighty":36.108181,"marketCap":34794400000},{"date":"2024-02-23","current":26.457355,"twenty":25.369207,"median":30.717545,"eighty":35.899805,"marketCap":35428800000},{"date":"2024-03-01","current":26.003824,"twenty":25.387892,"median":30.635655,"eighty":35.803782,"marketCap":34843200000},{"date":"2024-03-08","current":26.210688,"twenty":25.395134,"median":30.572064,"eighty":35.667709,"marketCap":35136000000},{"date":"2024-03-15","current":30.241869,"twenty":25.409765,"median":30.44783,"eighty":35.490153,"marketCap":40504000000},{"date":"2024-03-22","current":31.217759,"twenty":25.435494,"median":30.569793,"eighty":35.18968,"marketCap":41772800000},{"date":"2024-03-28","current":26.416103,"twenty":25.461641,"median":30.551779,"eighty":34.970062,"marketCap":41528800000},{"date":"2024-04-05","current":26.713065,"twenty":25.484582,"median":30.44783,"eighty":34.88282,"marketCap":41968000000},{"date":"2024-04-12","current":27.194611,"twenty":25.506915,"median":30.285025,"eighty":34.259259,"marketCap":42748800000},{"date":"2024-04-19","current":29.268508,"twenty":25.516475,"median":30.168532,"eighty":34.060481,"marketCap":45969600000},{"date":"2024-04-26","current":29.89571,"twenty":25.531167,"median":29.89571,"eighty":33.867614,"marketCap":46896800000},{"date":"2024-05-03","current":31.286129,"twenty":25.569811,"median":29.89571,"eighty":33.72816,"marketCap":49044000000},{"date":"2024-05-10","current":35.317002,"twenty":25.600357,"median":30.150227,"eighty":34.911901,"marketCap":51288800000},{"date":"2024-05-17","current":33.551674,"twenty":25.608792,"median":30.245106,"eighty":35.034138,"marketCap":48653600000},{"date":"2024-05-24","current":33.729665,"twenty":25.66112,"median":30.409033,"eighty":35.021714,"marketCap":48800000000},{"date":"2024-05-31","current":34.458991,"twenty":25.697876,"median":30.512617,"eighty":34.936642,"marketCap":49905929000},{"date":"2024-06-07","current":35.513458,"twenty":25.700826,"median":30.572064,"eighty":35.034138,"marketCap":51369298000},{"date":"2024-06-14","current":33.485895,"twenty":25.715973,"median":30.610294,"eighty":35.023883,"marketCap":48392099000},{"date":"2024-06-21","current":32.121521,"twenty":25.745773,"median":30.694377,"eighty":34.964455,"marketCap":46323198000},{"date":"2024-06-28","current":32.099848,"twenty":25.775731,"median":30.739187,"eighty":34.884174,"marketCap":46272737000},{"date":"2024-07-05","current":29.936022,"twenty":25.803458,"median":30.671209,"eighty":34.879736,"marketCap":43144155000},{"date":"2024-07-12","current":29.087996,"twenty":25.812746,"median":30.592469,"eighty":34.858532,"marketCap":41983552000},{"date":"2024-07-19","current":27.898783,"twenty":25.84406,"median":30.569793,"eighty":34.80307,"marketCap":40267878000},{"date":"2024-07-26","current":27.412372,"twenty":25.847354,"median":30.44783,"eighty":34.722361,"marketCap":39712807000},{"date":"2024-08-02","current":26.870727,"twenty":25.853895,"median":30.347362,"eighty":34.692602,"marketCap":38905431000},{"date":"2024-08-09","current":29.53175,"twenty":25.868681,"median":30.263126,"eighty":34.580226,"marketCap":43043233000},{"date":"2024-08-16","current":27.651468,"twenty":25.880225,"median":30.20526,"eighty":34.54918,"marketCap":40318339000},{"date":"2024-08-23","current":20.295155,"twenty":25.847354,"median":30.132576,"eighty":34.503268,"marketCap":39157736000},{"date":"2024-08-30","current":21.43279,"twenty":25.766624,"median":29.936022,"eighty":34.476088,"marketCap":41630325000},{"date":"2024-09-06","current":20.565575,"twenty":25.695677,"median":29.843348,"eighty":34.445054,"marketCap":39965112000},{"date":"2024-09-13","current":18.849184,"twenty":25.540828,"median":29.786096,"eighty":34.363297,"marketCap":36533764000},{"date":"2024-09-20","current":20.082561,"twenty":25.484582,"median":29.694562,"eighty":34.259259,"marketCap":39157736000},{"date":"2024-09-27","current":24.850231,"twenty":25.394448,"median":29.657792,"eighty":34.060481,"marketCap":48745326000},{"date":"2024-10-04","current":29.382648,"twenty":25.395362,"median":29.624666,"eighty":34.023673,"marketCap":57374157000},{"date":"2024-10-10","current":27.207172,"twenty":25.409765,"median":29.557165,"eighty":33.926357,"marketCap":52782206000},{"date":"2024-10-18","current":27.08831,"twenty":25.435494,"median":29.436062,"eighty":33.784845,"marketCap":52277596000},{"date":"2024-10-25","current":27.691447,"twenty":25.469288,"median":29.344363,"eighty":33.707844,"marketCap":53438199000},{"date":"2024-11-01","current":28.012496,"twenty":25.497982,"median":29.274876,"eighty":33.690002,"marketCap":54094192000},{"date":"2024-11-08","current":29.463901,"twenty":25.512651,"median":29.272452,"eighty":33.684759,"marketCap":56465859000},{"date":"2024-11-15","current":26.265769,"twenty":25.52529,"median":29.194481,"eighty":33.660087,"marketCap":49956390000},{"date":"2024-11-22","current":26.278217,"twenty":25.56015,"median":29.088985,"eighty":33.628618,"marketCap":49956390000},{"date":"2024-11-29","current":26.561468,"twenty":25.595136,"median":29.046664,"eighty":33.578085,"marketCap":50461000000},{"date":"2024-12-06","current":27.316407,"twenty":25.595136,"median":28.89327,"eighty":33.512207,"marketCap":51772986000},{"date":"2024-12-13","current":27.527865,"twenty":25.608792,"median":28.855293,"eighty":33.470601,"marketCap":52126213000},{"date":"2024-12-20","current":27.519045,"twenty":25.66112,"median":28.7635,"eighty":33.433798,"marketCap":51823447000},{"date":"2024-12-27","current":26.95045,"twenty":25.695677,"median":28.729978,"eighty":33.410147,"marketCap":50713305000},{"date":"2025-01-03","current":25.718533,"twenty":25.700075,"median":28.694216,"eighty":33.386493,"marketCap":48442560000},{"date":"2025-01-10","current":26.596222,"twenty":25.605578,"median":28.598093,"eighty":33.385259,"marketCap":49905929000},{"date":"2025-01-17","current":28.4557,"twenty":25.610934,"median":28.581538,"eighty":33.383573,"marketCap":53438199000},{"date":"2025-01-24","current":29.058848,"twenty":25.694577,"median":28.62658,"eighty":33.365541,"marketCap":54912816000},{"date":"2025-01-28","current":30.995109,"twenty":25.696776,"median":28.668851,"eighty":33.362531,"marketCap":58878741600},{"date":"2025-02-07","current":31.279146,"twenty":25.700576,"median":28.706002,"eighty":33.347316,"marketCap":59082122400},{"date":"2025-02-14","current":32.46032,"twenty":25.708209,"median":28.7635,"eighty":33.295849,"marketCap":61166775600},{"date":"2025-02-21","current":32.605291,"twenty":25.726297,"median":28.850334,"eighty":33.213923,"marketCap":61776918000},{"date":"2025-02-28","current":33.709306,"twenty":25.745773,"median":28.875802,"eighty":33.347316,"marketCap":63658190400},{"date":"2025-03-07","current":37.167941,"twenty":25.761386,"median":29.014465,"eighty":33.385999,"marketCap":70471447200},{"date":"2025-03-14","current":37.985438,"twenty":25.781535,"median":29.070262,"eighty":33.525362,"marketCap":72047648400},{"date":"2025-03-21","current":37.329923,"twenty":25.803863,"median":29.089974,"eighty":33.667635,"marketCap":70776518400},{"date":"2025-03-28","current":31.329348,"twenty":25.820414,"median":29.153791,"eighty":33.6911,"marketCap":69149472000},{"date":"2025-04-03","current":32.960917,"twenty":25.84406,"median":29.176551,"eighty":33.68679,"marketCap":72606945600},{"date":"2025-04-11","current":32.158951,"twenty":25.847354,"median":29.194481,"eighty":33.675182,"marketCap":70369756800}],"updateTime":1744538446912}}}